Study for therapeutic effect on malignant orbital tumor by I-125 particle strip implantation

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043148

Enrollment

Unknown

Registered

2021-02-06

Start date

2017-04-11

Completion date

Unknown

Last updated

2021-05-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

malignant orbital tumor

Interventions

Case series:Iodine-125 interstitial brachytherapy

Eligibility

Sex/Gender

All

Age

1 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Aged 1 to 90 years; 2. All patients were diagnosed with orbital malignant tumor; 3. No serious cardio-cerebrovascular disease; 4. No severe coagulation dysfunction; 5. ECOG score 0-3.

Exclusion criteria

Exclusion criteria: 1. Cachexia, unable to tolerate I-125 therapy; 2. Use with caution if the estimated survival time is less than 3 months; 3. Severe diabetes mellitus; 4. Cann't tolerate CT and MRI; 5. Women during pregnancy, lactation, or women of childbearing age who are willing to become pregnant.

Design outcomes

Primary

Measure	Time frame
MRI;	—

Countries

China

Contacts

Public ContactYang-Jun Li

Tangdu Hospital, Fourth Military Medical University

liyjun1969@126.com+86 15029226669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026